BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
T cell receptor signaling pathway
,
HIV infection
,
Breast
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tyrosine-protein kinase ABL1/transforming protein Abl
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon
Uterus
Myometrium
Saphenous vein
Smooth muscle
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of eye region
Varicella-zoster virus infection
Disorder of cornea
Bronchitis
Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Alpha-Amanitin
JNJ38877605
Methazolamide
heptanal
flavopiridol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Idd1
Idd5
C13orf42
ZCCHC4
PC
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
mRNA decay in MDA-MB-231 cells transfected with HNRPA2B1 siRNA
Lung biopsies from idiopathic pulmonary fibrosis patients
OMIM - Multiple congenital anomalies
T-cell Gene expression profiling of NOD mice and related congenic mice
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Tyrosine-protein kinase ABL1/transforming protein Abl
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelof…
Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic …
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in…
Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Mal…
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ